1-112509275-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024494.3(WNT2B):āc.13G>Cā(p.Gly5Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000658 in 1,534,644 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_024494.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WNT2B | NM_024494.3 | c.13G>C | p.Gly5Arg | missense_variant | 1/5 | ENST00000369684.5 | |
WNT2B | NM_001291880.1 | c.-94-5599G>C | intron_variant | ||||
WNT2B | NM_004185.4 | c.126-5599G>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WNT2B | ENST00000369684.5 | c.13G>C | p.Gly5Arg | missense_variant | 1/5 | 1 | NM_024494.3 | P1 | |
WNT2B | ENST00000369686.9 | c.126-5599G>C | intron_variant | 1 | |||||
WNT2B | ENST00000256640.9 | c.-94-5599G>C | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152188Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000603 AC: 8AN: 132648Hom.: 0 AF XY: 0.0000544 AC XY: 4AN XY: 73586
GnomAD4 exome AF: 0.0000608 AC: 84AN: 1382456Hom.: 0 Cov.: 32 AF XY: 0.0000629 AC XY: 43AN XY: 683306
GnomAD4 genome AF: 0.000112 AC: 17AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 14, 2023 | The c.13G>C (p.G5R) alteration is located in exon 1 (coding exon 1) of the WNT2B gene. This alteration results from a G to C substitution at nucleotide position 13, causing the glycine (G) at amino acid position 5 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 22, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 5 of the WNT2B protein (p.Gly5Arg). This variant is present in population databases (rs774022592, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with WNT2B-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at